Yi Ta Li

Yi Ta Li is currently the Chairman & President at CanCap Pharmaceutical Ltd. He is also the Deputy Chairman at SynCore Biotechnology Co., Ltd. and the Director, Chief Research & Development Officer at Sinphar Pharmaceutical Co. Ltd. Additionally, he holds positions as a Director at Ching Ta Investment Co. Ltd., Sunetic Biotech, Inc., Taiwan Bio Industry Organization, Taiwan Research-based Biopharmaceutical Manufacturers Assoc, ZuniMed Biotech Co., Ltd., and Taiwan Listed Cabinet Co. Association.
He is also the Vice President at Alexander von Humboldt-Stiftung.
Dr. Li previously worked as a Director at Monte Jade Science & Technology Association of Western Canada and as a Member-Supervisory Board at MediGene AG.
He completed his undergraduate and graduate studies at McGill University and holds a doctorate from the University of British Columbia.
He also has an MBA from National Taiwan University.